Shaomeng Wang

This inventor holds 81 USPTO granted patents and 40 published patent applications and 28 EPO patents, primarily in Protein Degraders (CPC class A61P35-00). Top assignees: University of Michigan, Georgetown University, Ascentage Pharma (Suzhou) Co., Ltd.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaomeng Wang. Retrieved from https://idiyas.com/inventor/shaomeng-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 81 (Patent Applications = 40)

% Patents Active = 60.5

EPO Patents = 28 (Patent Applications = 44)

Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 469(Granted Patents)

Forward Citations (Not Self Cited) = 382(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

McLean, VA (US) (2000)
McLeane, VA (US) (1999 - 2001)
Rockville, MD (US) (2004 - 2008)
Saline, MI (US) (2004 - 2017)
Superior Township, MI (US) (2017 - 2024)

Company Filing History:

71 out of 3,543

University of Michigan

patents

9 out of 499

Georgetown University

patents

3 out of 31

Ascentage Pharma (Suzhou) Co., Ltd.

patents

4. 3 out of 29

Ascentage Pharma Group Corp Limited

Adherex Technologies, Inc.

patents

7. 1 out of 1

Ascenta Licensing Corporation

patent

8. 1 out of 2

Jiangsu Ascentage Biomed Development Inc.

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

STAT3 Protein Degraders

MDM2 Inhibitors

BET Bromodomain Inhibitors

Small Molecule Inhibitors

ALK Inhibitors

Mcl-1 Inhibitors

Bcl-2 Inhibitors

LSD-1 Inhibitors

DCN1 Inhibitors

Covalent Inhibitors

Fused Pyrazoles

Indoloquinolone Compounds

81 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729213 - Small molecule degraders of STAT3 (2026-09-08),

2. 12637473 - MDM2 protein degraders (2026-05-26),

3. 12570679 - STAT3 protein degraders (2026-03-10),

4. 12522623 - Small molecule STAT protein degraders (2026-01-13),

5. 12319703 - Macrocyclic fused pyrazoles as Mcl-1 inhibitors (2025-06-03),

6. 12145944 - Imidazopyrimidines as EED inhibitors and the use thereof (2024-11-19),

7. 12012467 - Small molecule DCN1 inhibitors and therapeutic methods using the same (2024-06-18),

8. 11944614 - Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors (2024-04-02),

9. 11718613 - N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors (2023-08-08),

10. 11691989 - Macrocyclic indoles as Mcl-1 inhibitors (2023-07-04),

11. 11548899 - Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors (2023-01-10),

12. 11498928 - Macrocyclic spiroethers as Mcl-1 inhibitors (2022-11-15),

13. 11466028 - Fused 1,4-oxazepines as BET protein degraders (2022-10-11),

14. 11267822 - BET bromodomain protein degraders with cleavable linkers (2022-03-08),

15. 11192898 - MDM2 protein degraders (2021-12-07),

Title: The Innovative Journey of Shaomeng Wang

Introduction: Shaomeng Wang, a pioneering inventor based in Saline, MI (US), has made significant contributions to the field of innovation through his groundbreaking work in various patents and inventions.

Latest Patents: Shaomeng Wang holds several patents in the areas of pharmaceuticals and biotechnology, with his most recent patent focusing on a novel drug delivery system for targeted cancer therapy.

Career Highlights: Wang's illustrious career includes serving as a lead researcher at a prominent pharmaceutical company, where he spearheaded the development of cutting-edge treatments for complex diseases. His innovative approach to drug discovery has led to the successful commercialization of several life-saving medications.

Collaborations: Throughout his career, Shaomeng Wang has collaborated with top researchers, scientists, and medical professionals from renowned institutions and universities worldwide. His collaborative efforts have resulted in the publication of numerous research papers and the advancement of scientific knowledge in the field.

Conclusion: Shaomeng Wang's dedication to innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of inventors. His remarkable contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of science and technology.

Profile summary based on public USPTO records.